Sotalol Hydrochloride

CHEMBL1700 Phase 4 Aprovado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
308.8 g/mol
LogP
Phase
4

A hydrochloride salt form of sotalol with the same therapeutic properties. This dual-action medication both blocks beta-adrenergic receptors and stabilizes the heart's electrical rhythm by extending the action potential, making it useful for treating atrial fibrillation and serious ventricular arrhythmias.

Peso Molecular

308,8300 g/mol

TPSA

86,80 Ų

Áreas Terapêuticas

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estrutura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC(C)NCC(O)c1ccc(NS(C)(=O)=O)cc1.Cl

InChI

InChI=1S/C12H20N2O3S.ClH/c1-9(2)13-8-12(15)10-4-6-11(7-5-10)14-18(3,16)17;/h4-7,9,12-15H,8H2,1-3H3;1H

Molecular Formula

C12H21ClN2O3S

HBD / HBA

4 / 5

Ligações Rotacionáveis

6

Átomos Pesados

19

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

A hydrochloride salt form of sotalol with the same therapeutic properties. This dual-action medication both blocks beta-adrenergic receptors and stabilizes the heart's electrical rhythm by extending the action potential, making it useful for treating atrial fibrillation and serious ventricular arrhythmias.

Yes, Sotalol Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1700. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 66245. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.